With reference to Increase in Volume, Sun Pharma Advanced Research Company has clarified that there is no material information/announcement/ development (including pending/unpublished announcement) that could have triggered the jump in volume.They also confirm that the Company will promptly intimate to the stock exchanges any event, information etc. that have a material bearing on the operation/ performance of the Company in compliance with the requirements of clause 36 of the Listing Agreement.
The above information is a part of company’s filings submitted to BSE.
